Author: Richard Atkins

Richard Atkins is a senior contributor at Tech Insider covering online media, online travel, and video games. Richard has been with Tech Insider covering companies in these industries since 2011 and has authored numerous industry reports, including "Internet Video: Field of Dreams or Nightmare on Elm Street," "The Next Leg of Online Travel," and "Pwned: How Casual Games Changed The Gaming Landscape." Atkins was recognized as the No. 2 stock picker and earnings estimator in the 2011 Financial Times / StarMine Internet & Catalog Retail category and was ranked in the 2010 Wall Street Journal "Best On The Street" for the Leisure Goods & Services category.
Finance, Internet

Apple (NASDAQ AAPL) Stock News: Looking At The Apple Watch Features

Apple (NASDAQ AAPL) officially unveiled its Apple Watch product on Monday in an event which showcased all the features of the much anticipated product. Apple have been quite upbeat about the product and the market had been eagerly waiting for the product. Many were expecting this product to change the landscape of the wearable technology industry. While a lot of features make this product a … Continue reading Apple (NASDAQ AAPL) Stock News: Looking At The Apple Watch Features

Richard Atkins
BioTech, Stock Movers

BioTech in Focus: Myriad Genetics (NASDAQ:MYGN), Cantel Medical (NYSE:CMN), WuXi (NYSE:WX)

Myriad Genetics (NASDAQ:MYGN) is lower after the molecular diagnostic company disclosed in a regulatory filing Tuesday that the U.S. District Court for the District of Utah has denied the company’s motion for preliminary injunctive relief against Ambry Genetics’s sale of certain testing services that MYGN believes infringes on its patents. Shares are down 9.80% at $34.04, with a 52-week range of $20.02 – $39.15. Myriad … Continue reading BioTech in Focus: Myriad Genetics (NASDAQ:MYGN), Cantel Medical (NYSE:CMN), WuXi (NYSE:WX)

Richard Atkins
Finance

Solar Stocks: ReneSola (NYSE:SOL), Hanwha Solarone (NASDAQ:HSOL), SolarCity Corp (NASDAQ:SCTY), Yingli Green Energy (NYSE:YGE)

ReneSola Ltd. (ADR)(NYSE:SOL) on Mar. 5 announced it has delivered approximately 45,900 of its high-efficiency modules to the Photovoltaic Plant of Ferrara Aranova project, a 11.7MW ground-mounted solar project in Italy developed by Tozzi Sud S.p.A., an Italian designer, manufacturer, and installer of power plants. ReneSola Ltd. (ADR) (NYSE:SOL) stock performance was -5.23% in last session and finished the day at $3.99. Traded volume was … Continue reading Solar Stocks: ReneSola (NYSE:SOL), Hanwha Solarone (NASDAQ:HSOL), SolarCity Corp (NASDAQ:SCTY), Yingli Green Energy (NYSE:YGE)

Richard Atkins
BioTech

Biotech Unusual Volume: Agios Pharmaceuticals (NASDAQ:AGIO), OHR (NASDAQ:OHRP), La Jolla (NASDAQ:LJPC), Aastrom Biosciences (NASDAQ:ASTM)

Agios Pharmaceuticals (NASDAQ:AGIO) was downgraded by Zacks from a “neutral” rating to an “underperform” rating in a research report issued to clients and investors on Monday, Analyst Ratings News reports. Agios Pharmaceuticals Inc (NASDAQ:AGIO) stock performance was 2.84% in last session and finished the day at $46.74. Traded volume was 983,271 million shares in the last session and the average volume of the stock remained … Continue reading Biotech Unusual Volume: Agios Pharmaceuticals (NASDAQ:AGIO), OHR (NASDAQ:OHRP), La Jolla (NASDAQ:LJPC), Aastrom Biosciences (NASDAQ:ASTM)

Richard Atkins
BioTech

Biotech Top Gainers: Northwest Biotherapeutics (NASDAQ:NWBO), Alexion Pharmaceuticals (NASDAQ:ALXN), Merrimack Pharmaceuticals (NASDAQ:MACK), Enzon Pharmaceuticals (NASDAQ:ENZN)

German health regulators have granted Northwest Biotherapeutics Inc (NASDAQ:NWBO) special permission to sell its experimental brain cancer drug, DCVax-L, in the country, even though the small US biotechnology company has not yet completed its late-stage trial of the immunotherapy. Northwest Biotherapeutics, Inc (NASDAQ:NWBO) stock performance was 29.55% in last session and finished the day at $7.85. Traded volume was 6,155,092 million shares in the last … Continue reading Biotech Top Gainers: Northwest Biotherapeutics (NASDAQ:NWBO), Alexion Pharmaceuticals (NASDAQ:ALXN), Merrimack Pharmaceuticals (NASDAQ:MACK), Enzon Pharmaceuticals (NASDAQ:ENZN)

Richard Atkins
Stock Movers

Financial Movers: National Bank of Greece (NYSE:NBG), Freddie Mac (OTCBB:FMCC), Camtek (NASDAQ:CAMT), Rosetta Genomic (NASDAQ:ROSG)

Shares of National Bank of Greece (NYSE:NBG) are up nearly 10% Monday following Deutsche Bank’s new coverage of the stock at a Buy rating and EUR4.50 price target (approx $6.25 based on Monday’s exchange rate). The rating results from Deutsche Bank’s forecast for a strong recovery in fundamentals for the Greek banking sector. In addition, the bank will release Q4 earnings on March 27. It … Continue reading Financial Movers: National Bank of Greece (NYSE:NBG), Freddie Mac (OTCBB:FMCC), Camtek (NASDAQ:CAMT), Rosetta Genomic (NASDAQ:ROSG)

Richard Atkins